Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viking Therapeutics, Inc. (VKTX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viking Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1607678.
Total stock buying since 2015: $771,717.
Total stock sales since 2015: $129,602,464.
Total stock option exercises since 2015: $11,393,687.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,240 | $29,942 | 334,435 | $13,842,485 | 20,786 | $166,288 |
| 2024 | 0 | $0 | 1,545,754 | $87,786,037 | 1,135,540 | $6,286,537 |
| 2023 | 0 | $0 | 1,168,058 | $21,317,157 | 972,601 | $4,940,862 |
| 2022 | 45,000 | $111,195 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 177,488 | $1,423,268 | 0 | $0 |
| 2018 | 95,465 | $540,102 | 284,432 | $5,233,517 | 0 | $0 |
| 2016 | 33,000 | $40,478 | 0 | $0 | 0 | $0 |
| 2015 | 6,250 | $50,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 35,421 | $984,520 | 0 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 20,786 | $166,288 |
| 2025-03 | 1,240 | $29,942 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 299,014 | $12,857,965 | 0 | $0 |
| 2024-11 | 0 | $0 | 2,000 | $137,334 | 2,000 | $11,600 |
| 2024-10 | 0 | $0 | 158,687 | $12,458,528 | 121,001 | $754,508 |
| 2024-09 | 0 | $0 | 226,430 | $16,101,712 | 176,430 | $1,303,087 |
| 2024-08 | 0 | $0 | 156,356 | $10,152,340 | 156,356 | $1,111,120 |
| 2024-07 | 0 | $0 | 150,021 | $8,669,334 | 0 | $0 |
| 2024-05 | 0 | $0 | 348,181 | $27,057,156 | 315,674 | $1,945,130 |
| 2024-02 | 0 | $0 | 339,079 | $9,311,883 | 214,079 | $763,892 |
| 2024-01 | 0 | $0 | 165,000 | $3,897,750 | 150,000 | $397,200 |
| 2023-05 | 0 | $0 | 101,000 | $2,394,250 | 56,000 | $62,240 |
| 2023-04 | 0 | $0 | 476,872 | $9,262,458 | 364,872 | $1,699,476 |
| 2023-03 | 0 | $0 | 590,186 | $9,660,449 | 551,729 | $3,179,146 |
| 2022-05 | 45,000 | $111,195 | 0 | $0 | 0 | $0 |
| 2020-08 | 0 | $0 | 164,488 | $1,327,718 | 0 | $0 |
| 2020-06 | 0 | $0 | 13,000 | $95,550 | 0 | $0 |
| 2018-09 | 0 | $0 | 262,881 | $5,034,171 | 0 | $0 |
| 2018-05 | 95,465 | $540,102 | 21,551 | $199,346 | 0 | $0 |
| 2016-11 | 13,000 | $15,678 | 0 | $0 | 0 | $0 |
| 2016-04 | 20,000 | $24,800 | 0 | $0 | 0 | $0 |
| 2015-05 | 6,250 | $50,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-03 | Mancini Marianna (Chief Operating Officer) | Sale | 4,266 | 27.77 | 118,471 |
| 2025-07-03 | Lian Brian (President & CEO) | Sale | 26,889 | 27.80 | 747,621 |
| 2025-07-03 | Zante Greg (Chief Financial Officer) | Sale | 4,266 | 27.76 | 118,428 |
| 2025-04-11 | Foehr Matthew W | Option Ex | 20,786 | 8.00 | 166,288 |
| 2025-03-31 | Rouan Sarah Kathryn | Buy | 1,240 | 24.15 | 29,942 |
| 2025-01-06 | Mancini Marianna (Chief Operating Officer) | Sale | 54,215 | 43.00 | 2,331,407 |
| 2025-01-06 | Lian Brian (President & CEO) | Sale | 194,490 | 43.00 | 8,363,070 |
| 2025-01-06 | Zante Greg (Chief Financial Officer) | Sale | 50,309 | 43.00 | 2,163,488 |
| 2024-11-08 | Macartney Lawson | Sale | 2,000 | 68.67 | 137,334 |
| 2024-11-08 | Macartney Lawson | Option Ex | 2,000 | 5.80 | 11,600 |
| 2024-10-28 | Zante Greg (Chief Financial Officer) | Sale | 131,687 | 78.19 | 10,296,738 |
| 2024-10-28 | Zante Greg (Chief Financial Officer) | Option Ex | 94,001 | 6.69 | 629,148 |
| 2024-10-25 | Rouan Sarah Kathryn | Sale | 11,000 | 80.89 | 889,790 |
| 2024-10-25 | Rouan Sarah Kathryn | Option Ex | 11,000 | 4.88 | 53,680 |
| 2024-10-25 | Singleton J Matthew | Sale | 16,000 | 79.50 | 1,272,000 |
| 2024-10-25 | Singleton J Matthew | Option Ex | 16,000 | 4.48 | 71,680 |
| 2024-09-20 | Lian Brian (President & CEO) | Sale | 216,130 | 71.19 | 15,385,862 |
| 2024-09-20 | Lian Brian (President & CEO) | Option Ex | 166,130 | 7.77 | 1,290,830 |
| 2024-09-20 | Singleton J Matthew | Sale | 10,300 | 69.50 | 715,850 |
| 2024-09-20 | Singleton J Matthew | Option Ex | 10,300 | 1.19 | 12,257 |
| 2024-08-21 | Lian Brian (President & CEO) | Sale | 1,000 | 69.90 | 69,900 |
| 2024-08-21 | Lian Brian (President & CEO) | Option Ex | 1,000 | 7.77 | 7,770 |
| 2024-08-21 | Singleton J Matthew | Sale | 5,700 | 69.72 | 397,432 |
| 2024-08-21 | Singleton J Matthew | Option Ex | 5,700 | 1.19 | 6,783 |
| 2024-08-19 | Lian Brian (President & CEO) | Sale | 112,870 | 66.27 | 7,480,233 |
| 2024-08-19 | Lian Brian (President & CEO) | Option Ex | 112,870 | 7.77 | 876,999 |
| 2024-08-19 | Singleton J Matthew | Sale | 16,000 | 62.52 | 1,000,352 |
| 2024-08-19 | Singleton J Matthew | Option Ex | 16,000 | 3.33 | 53,280 |
| 2024-08-14 | Singleton J Matthew | Sale | 20,786 | 57.94 | 1,204,423 |
| 2024-08-14 | Singleton J Matthew | Option Ex | 20,786 | 8.00 | 166,288 |
| 2024-07-30 | Mancini Marianna (Chief Operating Officer) | Sale | 18,026 | 57.40 | 1,034,692 |
| 2024-07-30 | Lian Brian (President & CEO) | Sale | 115,859 | 57.85 | 6,702,095 |
| 2024-07-30 | Zante Greg (Chief Financial Officer) | Sale | 16,136 | 57.79 | 932,547 |
| 2024-05-03 | Zante Greg (Chief Financial Officer) | Sale | 66,756 | 74.87 | 4,998,221 |
| 2024-05-03 | Zante Greg (Chief Financial Officer) | Option Ex | 34,249 | 4.78 | 163,710 |
| 2024-05-01 | Mancini Marianna (Chief Operating Officer) | Sale | 281,425 | 78.38 | 22,058,935 |
| 2024-05-01 | Mancini Marianna (Chief Operating Officer) | Option Ex | 281,425 | 6.33 | 1,781,420 |
| 2024-02-09 | Lian Brian (President & CEO) | Sale | 45,000 | 29.90 | 1,345,500 |
| 2024-02-08 | Rouan Sarah Kathryn (Director) | Sale | 25,000 | 28.05 | 701,250 |
| 2024-02-08 | Rouan Sarah Kathryn (Director) | Option Ex | 25,000 | 8.32 | 208,000 |
| 2024-02-08 | Lian Brian (President & CEO) | Sale | 269,079 | 27.00 | 7,265,133 |
| 2024-02-08 | Lian Brian (President & CEO) | Option Ex | 189,079 | 2.94 | 555,892 |
| 2024-01-31 | Lian Brian (President & CEO) | Sale | 85,000 | 24.70 | 2,099,500 |
| 2024-01-31 | Lian Brian (President & CEO) | Option Ex | 85,000 | 1.23 | 104,550 |
| 2024-01-30 | Lian Brian (President & CEO) | Sale | 35,000 | 23.95 | 838,250 |
| 2024-01-30 | Lian Brian (President & CEO) | Option Ex | 35,000 | 1.23 | 43,050 |
| 2024-01-19 | Rouan Sarah Kathryn (Director) | Sale | 30,000 | 23.05 | 691,500 |
| 2024-01-19 | Rouan Sarah Kathryn (Director) | Option Ex | 30,000 | 8.32 | 249,600 |
| 2024-01-04 | Zante Greg (Chief Financial Officer) | Sale | 15,000 | 17.90 | 268,500 |
| 2023-05-16 | Macartney Lawson (Director) | Sale | 16,000 | 24.00 | 384,000 |
| 2023-05-16 | Macartney Lawson (Director) | Option Ex | 16,000 | 1.19 | 19,040 |
| 2023-05-16 | Rowland Charles A Jr (Director) | Sale | 40,000 | 25.00 | 1,000,000 |
| 2023-05-16 | Rowland Charles A Jr (Director) | Option Ex | 40,000 | 1.08 | 43,200 |
| 2023-05-01 | Lian Brian (President & CEO) | Sale | 45,000 | 22.45 | 1,010,250 |
| 2023-04-24 | Macartney Lawson (Director) | Sale | 16,000 | 22.00 | 352,064 |
| 2023-04-24 | Macartney Lawson (Director) | Option Ex | 16,000 | 3.33 | 53,280 |
| 2023-04-19 | Lian Brian (President & CEO) | Sale | 35,000 | 21.45 | 750,750 |
| 2023-04-17 | Mancini Marianna (Chief Operating Officer) | Sale | 12,500 | 20.00 | 250,000 |
| 2023-04-17 | Mancini Marianna (Chief Operating Officer) | Option Ex | 12,500 | 13.07 | 163,375 |
| 2023-04-17 | Lian Brian (President & CEO) | Sale | 155,000 | 20.45 | 3,169,750 |
| 2023-04-17 | Lian Brian (President & CEO) | Option Ex | 125,000 | 2.15 | 268,750 |
| 2023-04-17 | Macartney Lawson (Director) | Sale | 20,786 | 20.00 | 415,720 |
| 2023-04-17 | Macartney Lawson (Director) | Option Ex | 20,786 | 8.00 | 166,288 |
| 2023-04-17 | Zante Greg (Chief Financial Officer) | Sale | 7,500 | 20.00 | 150,000 |
| 2023-04-17 | Zante Greg (Chief Financial Officer) | Option Ex | 7,500 | 13.07 | 98,025 |
| 2023-04-13 | Lian Brian (President & CEO) | Sale | 79,336 | 18.45 | 1,463,749 |
| 2023-04-13 | Lian Brian (President & CEO) | Option Ex | 54,336 | 1.88 | 102,151 |
| 2023-04-12 | Zante Greg (Chief Financial Officer) | Sale | 41,544 | 18.00 | 747,792 |
| 2023-04-12 | Zante Greg (Chief Financial Officer) | Option Ex | 41,544 | 6.79 | 281,876 |
| 2023-04-11 | Zante Greg (Chief Financial Officer) | Sale | 56,295 | 18.00 | 1,013,535 |
| 2023-04-11 | Zante Greg (Chief Financial Officer) | Option Ex | 56,295 | 5.78 | 325,553 |
| 2023-04-03 | Lian Brian (President & CEO) | Sale | 22,000 | 17.85 | 392,700 |
| 2023-04-03 | Zante Greg (Chief Financial Officer) | Sale | 30,911 | 18.00 | 556,398 |
| 2023-04-03 | Zante Greg (Chief Financial Officer) | Option Ex | 30,911 | 7.77 | 240,178 |
| 2023-03-31 | Lian Brian (President & CEO) | Sale | 67,970 | 17.45 | 1,186,076 |
| 2023-03-31 | Lian Brian (President & CEO) | Option Ex | 67,970 | 9.49 | 645,035 |
| 2023-03-30 | Mancini Marianna (Chief Operating Officer) | Option Ex | 72,200 | 9.92 | 716,368 |
| 2023-03-30 | Lian Brian (President & CEO) | Sale | 153,382 | 17.20 | 2,638,170 |
| 2023-03-30 | Lian Brian (President & CEO) | Option Ex | 135,382 | 5.36 | 725,647 |
| 2023-03-30 | Zante Greg (Chief Financial Officer) | Sale | 131,029 | 17.00 | 2,227,886 |
| 2023-03-30 | Zante Greg (Chief Financial Officer) | Option Ex | 93,750 | 6.25 | 585,468 |
| 2023-03-29 | Mancini Marianna (Chief Operating Officer) | Sale | 41,242 | 16.00 | 659,872 |
| 2023-03-29 | Mancini Marianna (Chief Operating Officer) | Option Ex | 15,000 | 9.13 | 136,950 |
| 2023-03-28 | Mancini Marianna (Chief Operating Officer) | Sale | 196,563 | 15.00 | 2,948,445 |
| 2023-03-28 | Mancini Marianna (Chief Operating Officer) | Option Ex | 167,427 | 2.21 | 369,678 |
| 2022-05-02 | Foehr Matthew W (Director) | Buy | 45,000 | 2.47 | 111,195 |
| 2020-08-26 | Ligand Pharmaceuticals Inc (10% Owner) | Sale | 94,488 | 8.11 | 766,108 |
| 2020-08-25 | Ligand Pharmaceuticals Inc (10% Owner) | Sale | 70,000 | 8.02 | 561,610 |
| 2020-06-30 | Foehr Matthew W (Director) | Sale | 13,000 | 7.35 | 95,550 |
| 2018-09-25 | Ligand Pharmaceuticals Inc (10% Owner) | Sale | 262,881 | 19.15 | 5,034,171 |
| 2018-05-31 | Morneau Michael (VP, Finance and Administration) | Sale | 21,551 | 9.25 | 199,346 |
| 2018-05-31 | Singleton J Matthew (Director) | Buy | 9,500 | 9.82 | 93,261 |
| 2018-05-29 | Macartney Lawson (Director) | Buy | 47,965 | 5.22 | 250,329 |
| 2018-05-29 | Webster Stephen W (Director) | Buy | 8,000 | 5.21 | 41,712 |
| 2018-05-29 | Rowland Charles A Jr (Director) | Buy | 30,000 | 5.16 | 154,800 |
| 2016-11-15 | Foehr Matthew W (Director) | Buy | 13,000 | 1.21 | 15,678 |
| 2016-04-13 | Foehr Matthew W (Director) | Buy | 20,000 | 1.24 | 24,800 |
| 2015-05-04 | Foehr Matthew W (Director) | Buy | 6,250 | 8.00 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of VKTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viking Therapeutics, Inc. (symbol VKTX, CIK number 1607678) see the Securities and Exchange Commission (SEC) website.